Aspire Biopharma Holdings, Inc. 10-Q/A filing
Filed 2025-08-13 · Report date 2025-03-31 · 2025
Filing metadata
- Accession number
- 0001641172-25-023566
- Form type
- 10-Q/A
- CIK
- 0001847345
- Primary document
- https://www.sec.gov/Archives/edgar/data/1847345/000164117225023566/form10-qa.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspire Biopharma Holdings, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Net Income | $-15.9M | - | - |
| Total Assets | $2.0M | - | - |
| Total Liabilities | $9.9M | - | - |
| Shareholders Equity | $-8.0M | - | - |
| Operating Cash Flow | $-1.8M | - | - |